Clinical Trial Update: A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 study of aleglitazar in patients with a recent acute coronary syndrome and type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• Aleglitazar (Aleglitazar)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: COMPLETED